JS
Jeffrey S. Heier sold $77K of OCUL stock
Jeffrey S. Heier, Chief Scientific Officer of Ocular Therapeutix, Inc (OCUL), sold 10,869 shares of OCUL stock worth $77K, per an SEC Form 4 filed Oct 6, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 2, 2026, 4 days before it was made public.
OCUL has moved -20.0% since the trade date, from $6.96 to $5.57 (Nov 20, 2026 close).
- Traded
- Oct 2, 2026
- Disclosed
- Oct 6, 2026
- Filing delay
- 4 days
- Price since
- -20.0%
- Role
- Chief Scientific Officer
- Source
- SEC Form 4